Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Wednesday - 25 March 2026

Wednesday, 25 March 2026

Questions (315)

Richard Boyd Barrett

Question:

315. Deputy Richard Boyd Barrett asked the Minister for Health if she is aware of the cohort of women who are unable to take HRT due to a history of breast cancer, but for whom the drug veoza provides essential relief from vasomotor symptoms associated with menopause; if she will consider the inclusion of veoza in the drug payment scheme (DPS) as some women are being forced to abandon its usage given the prohibitive cost on top of the DPS payments they incur monthly; and if she will make a statement on the matter. [22497/26]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Share